158 related articles for article (PubMed ID: 23051787)
1. Expanding the innovation pool.
Nat Biotechnol; 2012 Oct; 30(10):897. PubMed ID: 23051787
[No Abstract] [Full Text] [Related]
2. Building a life sciences innovation ecosystem.
Harrison KD; Kadaba NS; Kelly RB; Crawford D
Sci Transl Med; 2012 Oct; 4(157):157fs37. PubMed ID: 23100622
[TBL] [Abstract][Full Text] [Related]
3. Japanese council urges reform of funding system.
Triendl R
Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
[No Abstract] [Full Text] [Related]
4. [Development of Human Health Discoveries. 10 years results of Young Innovative Company incubation].
Marsac J
Bull Acad Natl Med; 2014; 198(4-5):905-16. PubMed ID: 26753415
[TBL] [Abstract][Full Text] [Related]
5. Thanks for sharing.
Dolgin E
Nat Med; 2013 Dec; 19(12):1556-8. PubMed ID: 24309644
[No Abstract] [Full Text] [Related]
6. European biotechnology turns East.
Sansom C
Nat Biotechnol; 1999 May; 17(5):437-9. PubMed ID: 10331797
[No Abstract] [Full Text] [Related]
7. On the biotech block.
Ossola A
Nature; 2017 Oct; 550(7676):S168-S171. PubMed ID: 29045361
[No Abstract] [Full Text] [Related]
8. UK research funding.
Nat Cell Biol; 2009 Apr; 11(4):363. PubMed ID: 19337316
[No Abstract] [Full Text] [Related]
9. Fertile grounds.
Russo G
Nature; 2009 Oct; 461(7268):1308-9. PubMed ID: 19998548
[No Abstract] [Full Text] [Related]
10. Swiss on a roll.
Chipman A
Nature; 2007 Aug; 448(7153):525. PubMed ID: 17671476
[No Abstract] [Full Text] [Related]
11. Pay increases for nonfounder executives at private life sciences companies rebound.
Rychlik B
Nat Biotechnol; 2013 Mar; 31(3):259-61. PubMed ID: 23471072
[No Abstract] [Full Text] [Related]
12. Demise of the life science company begins.
Niiler E
Nat Biotechnol; 2000 Jan; 18(1):14. PubMed ID: 10625374
[No Abstract] [Full Text] [Related]
13. Corridor at the crossroads: Michigan.
Smaglik P
Nature; 2002 Nov; 420(6913):4-5. PubMed ID: 12447399
[No Abstract] [Full Text] [Related]
14. Executive pay goes up at private life sciences companies despite tumultuous economic climate.
Rychlik B; Brown E
Nat Biotechnol; 2010 Jan; 28(1):99-100. PubMed ID: 20062043
[No Abstract] [Full Text] [Related]
15. Best of both worlds.
Smaglik P
Nature; 2003 Dec; 426(6967):706-7. PubMed ID: 14668875
[No Abstract] [Full Text] [Related]
16. Blurred vision.
Smaglik P
Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
[No Abstract] [Full Text] [Related]
17. Biotech in Italy.
Biotechnol J; 2007 Mar; 2(3):298-300. PubMed ID: 17354217
[No Abstract] [Full Text] [Related]
18. Report: EuroBioFund first annual forum in Helsinki.
Biotechnol J; 2007 Apr; 2(4):406-7. PubMed ID: 17407205
[No Abstract] [Full Text] [Related]
19. Patent landscaping for life sciences innovation: toward consistent and transparent practices.
Bubela T; Gold ER; Graff GD; Cahoy DR; Nicol D; Castle D
Nat Biotechnol; 2013 Mar; 31(3):202-6. PubMed ID: 23471065
[No Abstract] [Full Text] [Related]
20. The ESF's EuroBioFund: sustainable research financing? Start with networking!
Thole E; Spek W
N Biotechnol; 2008 Jun; 25(1):20-1. PubMed ID: 18504007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
